BioMarin Pharmaceuticals BMRN Change in AP
Change in AP at other companies
Other financials
Where this comes from
Reported directly by BioMarin Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities.
The official record: BioMarin Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about BioMarin Pharmaceuticals's change in ap.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is BioMarin Pharmaceuticals's change in AP?
- BioMarin Pharmaceuticals (BMRN) reported change in AP of $3.1M in Q1 2026.
- How has BioMarin Pharmaceuticals's change in AP changed year-over-year?
- BioMarin Pharmaceuticals's change in AP increased by 216.8% year-over-year, from -$2.66M to $3.1M.
- What does change in AP mean?
- The change in money the company owes to its suppliers.
- How do you interpret change in AP?
- An increase provides a cash inflow; a decrease represents a cash outflow as the company pays down its obligations.
- How does change in AP compare across companies?
- Standard metric; peers with strong bargaining power often maintain higher payable balances.